Obesity

ICD-11: 5B81

Disease Overview

Obesity is a multifactorial condition characterized by excess adipose tissue accumulation, with body mass index (BMI) ≥30 kg/m² as a common threshold. Pathophysiology involves energy balance dysregulation, leptin–melanocortin signaling, gut–brain axis, adipose biology, and neuroendocrine pathways. Obesity increases risk for type 2 diabetes, cardiovascular disease, cancer, and musculoskeletal disorders. Genetic susceptibility is substantial: heritability for BMI is ~40–70%; SNP-based h² is ~0.21. Over 900 loci have been identified. Key genes include FTO (energy balance, hypothalamic regulation), MC4R (melanocortin-4 receptor, appetite), and loci in gut–brain axis (LEP, LEPR, POMC). Diet, physical activity, built environment, and psychosocial factors interact with genetic risk. Epigenetic programming in early life may influence susceptibility. Adolescence is a critical period for establishing weight trajectory.

Ages 10–24 represent a critical window for weight trajectory. Pubertal timing and growth affect body composition. Diet and activity patterns established in adolescence persist. Screen time, sleep disruption, and psychosocial stress affect weight. Genetic risk manifests partly through appetite and satiety; adolescents with high PRS may benefit from structured lifestyle intervention. Bariatric surgery is increasingly considered for severe adolescent obesity. Stigma and mental health are significant concerns. Early intervention may prevent adult obesity and comorbidities.

Genetic Architecture Summary

GeneVariantGWAS pEvidenceStrength
FTOrs99396091.0e-50Fat mass and obesity-associated; hypothalamic energy balance; affects food intake and preference; strongest common BMI locus0.92
MC4Rrs177823131.0e-40Melanocortin-4 receptor; leptin–melanocortin pathway; appetite regulation; monogenic obesity when mutated0.9
TMEM18rs65482381.0e-25Hypothalamic expression; energy balance; gut–brain axis0.82
BDNFrs62651.0e-15Brain-derived neurotrophic factor; hypothalamic energy homeostasis; synaptic plasticity0.75

Heritability

h² SNP: 0.21; h² narrow-sense: 0.55 GIANT consortium and twin studies (2019)

PRS notes: BMI/obesity PRS show moderate predictive ability (AUC ~0.60–0.68). Transferability is limited: European discovery; performance in non-European populations is reduced. PRS may identify individuals for intensified prevention; clinical utility is investigational. G×E (diet, physical activity, built environment) not yet integrated. PRS explain variance but lifestyle remains modifiable.

Exposure Modifier Panel

ExposureDirectionStrengthConfidenceMechanism hypothesis
diet-qualityamplify0.9HIGHEnergy-dense, low-satiety diets (ultra-processed foods, sugar-sweetened beverages) amplify genetic susceptibility; diet is primary modifiable factor
psychosocial-stressamplify0.7HIGHChronic stress affects cortisol, reward circuitry, and eating behavior; stress-induced eating; bidirectional with depression
obesity-exposureamplify0.75HIGHObesogenic environment (food access, marketing, physical inactivity) amplifies genetic risk; built environment and policy
alcoholamplify0.55MEDIUMAlcohol provides empty calories; affects appetite and fat metabolism; contributes to weight gain

Population Equity Notes

GWAS ancestry breakdown: BMI GWAS are predominantly European (~80%); GIANT and others are expanding multi-ancestry data

Transferability notes: FTO and many loci transfer across ancestries; effect sizes and allele frequencies vary. PRS performance in African, Hispanic, and Asian populations is reduced. Obesity prevalence and sequelae differ by race/ethnicity and socioeconomic status; equity in prevention and care is critical.

Data gaps: Under-representation of diverse ancestries; G×E (diet, built environment) across populations; childhood/adolescent obesity genetics; epigenetic contributions.

Tissue Context

hypothalamus0.98
adipose tissue0.95
gut (enteroendocrine cells)0.88
liver0.82

Mechanism Brief Links

Visualizations

Risk Shift by Exposure Stratum

Population-level data only — does not predict individual risk

Tissue Relevance

References

  1. 1.Speliotes EK, et al. (2010). Genome-wide association study for obesity. Nature Genetics. doi:10.1038/ng.620
  2. 2.Loos RJF, Yeo GSH (2014). FTO and the genetics of obesity. Trends in Genetics. doi:10.1016/j.tig.2014.06.002
  3. 3.Loos RJF, et al. (2008). MC4R and body weight regulation. Nature Genetics. doi:10.1038/ng.277
  4. 4.Dallman MF, et al. (2003). Stress and obesity. Proceedings of the National Academy of Sciences. doi:10.1073/pnas.1934666100
  5. 5.Traversy G, Chaput JP (2015). Alcohol consumption and obesity. Current Obesity Reports. doi:10.1007/s13679-015-0147-x